Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Beclometasone Dipropionate in Children With Allergic Rhinitis
NCT02646904Phase 4Completed
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of beclomethasone dipropionate in allergic rhinitis (AR) (2 arms). Primary endpoint: Nasal patency evaluated by acoustic rhinometry at 21 days. Started May 2016; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02646904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646904.